The study finds prune pectins inhibit B16F10 melanoma cells while sparing BALB/c 3T3 cells, indicating potential as a cancer treatment.
Fruit‑derived pectins exhibit notable biological effects, particularly against tumor cells. Consequently, natural products have become a major focus in the search for novel anticancer agents with fewer side‑effects. The present study evaluated the effects of a pectic fraction extracted from prunes (dried fruits of Prunus domestica), a species cultivated worldwide, on B16F10 cells. The prune pectic fraction obtained with hot water (PWH) reduced the viability of B16F10 murine melanoma cells, while leaving normal BALB/c 3T3 cells unaffected, indicating lower cytotoxicity than the chemotherapeutic drug, doxorubicin. At concentrations of 10 and 100 µg/ml, PWH specifically inhibited B16F10 cell viability by 24 and 40%, respectively, reduced colony formation by 20 and 26%, respectively, and decreased cytoplasmic extensions by 30% at 100 µg/ml. Furthermore, FAK gene expression increased by 57 and 200%, suggesting a compensatory response to mitigate the cell area loss. Collectively, these results underscore the potential of PWH for further cancer research.
No takes yet. Share an insight, caveat, or question.
Bialli et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: